Merck KGaA: The DAX Giant Acquires Bio-Techne for 11 Billion USD and Simultaneously Accelerates the AI Chip Turbo.
Reading Time: 2 minutes
In the DAX, Merck KGaA breaks out of the correction since 2022. Such a movement has high significance, which is why it is important to look at the reasons. The 11 Billion USD Coup: How Bio-Techne is Transforming the Life Science Sector On June 25, 2026, Merck made a takeover bid. For 73 USD per share in cash, or 11.3 billion USD, Bio-Techne is to be acquired. This secures Merck a portfolio driven by consumables, which accounts for 81% of Bio-Techne's total sales. The Americans are leaders in proteomics, spatial biology, and cell therapy. Through...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
